Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for Restless Legs Syndrome
NCT00584246Phase 4Withdrawn
- Sponsor
- University of South Florida
- Start
- Nov 2007
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in restless legs syndrome (RLS) comparing Pregabalin (Lyrica) with Placebo (2 arms). Primary endpoint: International RLS Study Group Severity Scale at 2 months. Planned start Nov 2007; status: withdrawn.
02
Drugs
pregabalin
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT00584246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00584246.